怀孕时的处方:炎症性类风湿性疾病
Samantha Steele1, Iona Thorne2
1Department of Obstetric Medicine, Chelsea and Westminster NHS Foundation Trust, West Middlesex University Hospital, Isleworth, UK samantha.steele6@nhs.net.
Drug and therapeutics bulletin
|October 1, 2023
概括
在怀孕期间管理炎症性类风湿性疾病至关重要. 在怀孕之前实现疾病缓解,并在整个怀孕期间保持控制,可以改善母亲和孩子的结果.
科学领域:
- 类风湿病学 类风湿病学
- 产科 产科 产科 产科 产科
- 药理学 药理学 是一个学科.
背景情况:
- 在怀孕期间,炎症性类风湿性疾病 (IRD) 带来了独特的挑战.
- 成功的怀孕结果取决于疾病的缓解和控制.
研究的目的:
- 讨论IRDs对怀孕的影响,反之亦然.
- 强调怀孕前的护理和协作产科-风湿病学管理.
- 审查怀孕前,怀孕期间和怀孕后的处方做法.
主要方法:
- 在怀孕期间对IRD的文献综述.
- 疾病影响和管理策略的分析.
- 在怀孕期间专注于药物治疗.
主要成果:
- 怀孕时的疾病缓解是成功怀孕的关键.
- 怀孕可以影响IRD活动,反之亦然.
- 在整个怀孕过程中,优化药物治疗至关重要.
结论:
- 怀孕前的咨询和计划至关重要.
- 产科医生和风湿病学家之间的多学科合作是必不可少的.
- 谨慎的药物治疗管理对于安全有效的治疗至关重要.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
186
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
186
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
164
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
164
Rheumatic Heart Disease III: Medical Management
11
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
11
Inflammatory Bowel Disease IV: Pharmacological Management
145
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
145
Rheumatic Heart Disease IV: Nursing Management
18
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
18
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
144
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
144


